Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti–PD-(L)1 Therapies in Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti–PD-(L)1 Therapies in Non–Small Cell Lung Cancer

Published:2019-05-13 Issue:16 Volume:25 Page:5015-5026
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Fang Wenfeng,Ma Yuxiang,Yin Jiani C.,Hong Shaodong,Zhou Huaqiang^ORCID,Wang Ao,Wang Fufeng,Bao Hua,Wu Xue^ORCID,Yang Yunpeng,Huang Yan,Zhao Hongyun,Shao Yang W.,Zhang Li

Funder

National Key R&D Program of China

Science and Technology Program of Guangdong

Chinese National Science Foundation

Sun Yat-sen University

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials;Science China Life Sciences;2024-09-12

2. Anlotinib reversed resistance to PD-1 inhibitors in recurrent and metastatic head and neck cancers: a real-world retrospective study;Cancer Immunology, Immunotherapy;2024-08-06

3. Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non–Small Cell Lung Cancer;JCO Precision Oncology;2024-08

4. Recommendations for Tumor Mutational Burden Assay Validation and Reporting;The Journal of Molecular Diagnostics;2024-08

5. Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung;npj Precision Oncology;2024-06-03